CIK 0001583771 · Non-accelerated filer<br>Smaller reporting company
Hepion Pharmaceuticals, Inc.
Sign in to watch- Tickers
- HEPA CTRVP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462783806
- Phone
- 732-902-4000
- Business address
- 34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ, 07701
- Former names
- ContraVir Pharmaceuticals, Inc.
Securities
- HEPA Common stock OTC
- CTRVP Common stock OTC
- Open-market buys, last 90 days
- $10,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$10,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 28 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-06 | Cavan John T CFO | Grant or award | +46,726 | 66,726 | ||
| 2017-07-06 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award | +141,061 | 170,727 | ||
| 2017-07-06 | Sullivan-Bolyai John Z Chief Medical Officer | Grant or award | +58,681 | 58,681 | ||
| 2017-07-06 | Foster Robert T Chief Scientific Officer | Grant or award | +44,082 | 44,082 | ||
| 2017-06-20 | Cavan John T CFO | Purchase | +20,000 | $0.65 | $13K | 20,000 |
| 2017-04-10 | HOWSON TAMAR D Director | Grant or award · Stock Options | +35,000 | 80,000 | ||
| 2017-03-06 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award · Stock Options | +313,898 | 2,761,129 | ||
| 2017-03-03 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award · Stock Options | +313,898 | 2,447,231 | ||
| 2016-10-27 | SAPIRSTEIN JAMES Chief Executive Officer | Option exercise | +16,666 | $1.50 | $25K | 29,666 |
| 2016-10-27 | SAPIRSTEIN JAMES Chief Executive Officer | Option exercise · Stock Options | −16,666 | 2,133,334 | ||
| 2016-08-26 | Sullivan-Bolyai John Z Chief Medical Officer | Grant or award · Stock Options | +135,790 | 290,790 | ||
| 2016-08-26 | Cavan John T Chief Financial Officer | Grant or award · Stock Options | +18,688 | 118,688 | ||
| 2016-07-19 | Lippa Arnold Director | Grant or award · Stock Options | +32,500 | 77,500 | ||
| 2016-07-19 | Block Timothy M. Director | Grant or award · Stock Options | +65,000 | 169,688 | ||
| 2016-07-19 | BRANCACCIO JOHN P Director | Grant or award · Stock Options | +65,000 | 200,656 | ||
| 2016-07-19 | JACOB GARY S Director | Grant or award · Stock Options | +65,000 | 1,015,000 | ||
| 2016-06-13 | Sullivan-Bolyai John Z Chief Medical Officer | Grant or award · Stock Options | +20,000 | 155,000 | ||
| 2016-06-13 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award · Stock Options | +500,000 | 2,150,000 | ||
| 2016-02-18 | SAPIRSTEIN JAMES Chief Executive Officer | Purchase | +10,000 | $1.00 | $10K | 13,000 |
Page 6 of 6 · 119 trades